SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+7.05%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$427M
AUM Growth
+$427M
(+54%)
Cap. Flow
+$139M
Cap. Flow
% of AUM
32.43%
Top 10 Holdings %
Top 10 Hldgs %
57.06%
Holding
143
New
47
Increased
27
Reduced
21
Closed
35
Top Buys
| 1 |
Novartis
NVS
|
$42.9M |
| 2 |
Sanofi
SNY
|
$33.4M |
| 3 |
Johnson & Johnson
JNJ
|
$21.2M |
| 4 |
Eli Lilly
LLY
|
$17.7M |
| 5 |
Merck
MRK
|
$14.2M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$9.18M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$7.75M |
| 3 |
Invesco QQQ Trust
QQQ
|
$7.1M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$4.67M |
| 5 |
Apple
AAPL
|
$3.1M |
Sector Composition
| 1 | Healthcare | 75.14% |
| 2 | Consumer Discretionary | 3.07% |
| 3 | Technology | 2.73% |
| 4 | Industrials | 1.88% |
| 5 | Consumer Staples | 1.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
NCR Voyix
VYX
$1.73B
| $1.75M | 0.4% |
+47,840
| New | +$1.75M |
|
|
CBIO
52
Crescent Biopharma, Inc. Common Stock
CBIO
$185M
| $1.73M | 0.4% |
+106,000
| New | +$1.73M |
|
53
Costco
COST
$419B
| $1.72M | 0.39% |
15,409
-12,445
| -45% | -$1.39M |
|
|
FLXN
54
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.71M | 0.39% |
+103,955
| New | +$1.71M |
|
|
RXDX
55
DELISTED
Ignyta, Inc.
RXDX
| $1.7M | 0.39% |
+205,000
| New | +$1.7M |
|
56
uniQure
QURE
$926M
| $1.56M | 0.36% |
+100,000
| New | +$1.56M |
|
|
GNVC
57
DELISTED
GenVec, Inc.
GNVC
| $1.52M | 0.35% |
+575,000
| New | +$1.52M |
|
|
AMPE
58
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $1.43M | 0.33% |
+225,000
| New | +$1.43M |
|
59
Vertex Pharmaceuticals
VRTX
$102B
| $1.41M | 0.32% |
+20,000
| New | +$1.41M |
|
|
RLYP
60
DELISTED
RELYPSA INC COM
RLYP
| $1.41M | 0.32% |
47,300
+17,300
| +58% | +$516K |
|
61
Ironwood Pharmaceuticals
IRWD
$210M
| $1.39M | 0.32% |
112,484
-232,516
| -67% | -$2.87M |
|
62
TG Therapeutics
TGTX
$5.01B
| $1.38M | 0.32% |
+200,000
| New | +$1.38M |
|
|
CTIC
63
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $1.36M | 0.31% |
+400,000
| New | +$1.36M |
|
|
AMBI
64
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $1.35M | 0.31% |
148,468
-85,527
| -37% | -$780K |
|
|
BLRX
65
BioLineRX
BLRX
$15.8M
| $1.34M | 0.31% |
+600,000
| New | +$1.34M |
|
66
Insmed
INSM
$30.6B
| $1.33M | 0.3% |
70,000
+23,000
| +49% | +$438K |
|
|
BLUE
67
DELISTED
bluebird bio
BLUE
| $1.31M | 0.3% |
57,435
-35,000
| -38% | -$796K |
|
|
OCRX
68
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $1.28M | 0.29% |
121,148
+106,267
| +714% | +$1.12M |
|
|
TLOG
69
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
| $1.28M | 0.29% |
200,000
+25,000
| +14% | +$160K |
|
|
IMMU
70
DELISTED
Immunomedics Inc
IMMU
| $1.26M | 0.29% |
+300,000
| New | +$1.26M |
|
|
PLXP
71
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $1.26M | 0.29% |
+125,000
| New | +$1.26M |
|
72
Bread Financial
BFH
$3.04B
| $1.25M | 0.29% |
+4,596
| New | +$1.25M |
|
73
Curis
CRIS
$21.1M
| $1.24M | 0.28% |
+438,800
| New | +$1.24M |
|
74
Cytokinetics
CYTK
$5.79B
| $1.24M | 0.28% |
130,000
-37,000
| -22% | -$352K |
|
|
GALTW
75
DELISTED
Galectin Therapeutics Inc. - Warrants
GALTW
| $1.23M | 0.28% |
+80,000
| New | +$1.23M |
|